At the Jefferson Brain Tumor Center, our physicians and neuroscientists are dedicated to finding new therapies for people living with brain tumors. We offer numerous leading-edge clinical trials for our patients and are involved in ongoing brain tumor research.
Jefferson Health has always been a hub for neuro-oncology research. Our physicians were the lead research team on The Lancet study that proved the efficacy of stereotactic radiosurgery for brain metastases.
Currently, our researchers are developing an immunotherapy method that may help those with glioblastoma. We are also home to a biorepository accredited by the College of American Pathologists, which specializes in banking tumor tissue, with an emphasis on pituitary tumors. This bank will allow Jefferson neurosurgeons and pathologists to identify tissue characteristics that may appear again later. This information will be used to provide individualized follow-up care to patients.
Enrollment in clinical trials is ongoing. If your doctor believes you may be a candidate for study participation, he or she will discuss it with you first. A research coordinator will be made available to answer any questions and enroll you in the trial, depending on your eligibility.